Barclays »

Rani Therapeutics Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 39 0.00

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
United Services Automobile Association
Alphabet
Stifel Financial
Geode Capital Management
Bank of America Corporation
BlackRock
Marc Lasry
Luther King Capital Management Corporation
Bridgeway Capital Management
Mot
Brown Advisory Holdings Incorporated
Alpha Square Group S
Citadel Advisors
XR Securities

View all funds holding Rani Therapeutics Hldgs